期刊文献+

雌二醇诱导子宫内膜癌细胞产生的VEGF、bFGF对PI3K/AKT通路的影响 被引量:5

THE EFFECTS OF VEGF AND BFGF INDUCED BY ESTROGEN ON PI3K/AKT PATHWAY OF ENDOMETRIAL CANCER CELL
下载PDF
导出
摘要 目的:探讨雌二醇(E2)诱导子宫内膜癌Ishikawa细胞生成的血管内皮生长因子(VEGF)和碱性成纤维细胞生长因子(bFGF)对磷脂酰肌醇3激酶/蛋白激酶B(PI3K/AKT)通路的主要基因蛋白的影响。方法:(1)以不同浓度E2作用于Ishikawa细胞30min后,采用蛋白印迹法检测p-AKT蛋白水平。(2)实验设3组:1对照组;2E2组;3抑制剂+E2组(包括BIBF1120+E2组、Ponatinib+E2组和LY294002+E2组),用荧光定量PCR和蛋白印迹法分别检测子宫内膜癌细胞内VEGF、bFGF、PI3K、AKT基因及蛋白的表达,流式细胞仪检测细胞周期的变化,Transwell检测细胞迁移能力。结果:(1)不同浓度(分别为0.01,0.1,1,10,100μmol/L)的E2作用30min后Ishikawa细胞中p-AKT蛋白的表达水平均高于对照组(P<0.05),且E2浓度为1μmol/L时其表达水平最高;(2)E2组中VEGF、bFGF、PI3K、AKT mRNA及VEGF、bFGF、p-PI3K、p-AKT蛋白活化水平均高于对照组(均P<0.05)。BIBF1120+E2组、Ponatinib+E2组、LY294002+E2组细胞中PI3K、AKT基因及p-PI3K、pAKT蛋白的表达均低于E2组(均P<0.05);(3)E2组与对照组相比,G1期细胞比例减少,S期细胞比例增加(均P<0.05),迁移穿过微孔的细胞增加(均P<0.05)。LY294002+E2组、BIBF1120+E2组、Ponatinib+E2组分别与E2组相比,G1期细胞比例增加,S期细胞比例减少(均P<0.05),迁移穿过微孔的细胞减少(均P<0.05)。结论:E2通过非基因转录效应产生VEGF、bFGF可以激活PI3K/AKT通路,促进子宫内膜癌的发生和转移。 Objective: To investigate the effects of VEGF and bFGF induced by estrogen on PI3K/AKT pathway of endometrial cancer Ishikawa cells. Methods: (1)Western blot was used to detect the expression of phosphorylation AKT (p-AKT) protein in Ishikawa cell after stimulated with different concentrations of estradiol (0.01,0.1,1,10,100 μmol/L) for 30 mim. (2) There were 3 groups in the experiment:(1)control group;(2)E2 group; (3) Inhibitor+ E2 group: including BIBFll20 + E2 group, Ponatinib + E2 group and LY294002+ E2 group. And then mRNA level of VEGF,bFGF,PI3K,AKT and its relative protein respectively detected by qRT-PCR and western blot. Flow cytometry was used to examine the change of cell cycle, and transwell assay was used to detect the cell migration in different groups. Results: (1)The expression of the p-AKT protein at 0. 01,0.1,1,10,100 μmol/L E2 were significantly higher than that of control group, and when the concentration of E2 was 1 μmol/L, the expression of p-AKT was highest( P 〈0.05).(2) The mRNA levels of VEGF, bFGF, PI3K, AKT and the protein of VEGF,p-PI3K,p-AKT in E2 group were higher than that of control group( P〈0.05). The mRNA of PI3K and AKT ,and the protein of p- PI3K,p-AKT in BIBF1120+E2 group,Ponatinib+E2 group and LY294002-t-E2 group were together lowerthan that of Ez group( P d0.05). (3)Compared with the control group, the results of cell cycle of E2 group showed that percentage of G1 phase was decrease and S phase was significantly increase ( P〈 0.05). But when compared with E2 group, opposite result showed in LY294002 + E2 group, BIBF1120 + E2 group or ponatinib+E2group (P 〈0. 05). Transwell assay also showed that the number of cell migration in E2 group was higher than that of control group but significantly lower than that of LY294002+E2 group, BIBF1120+E2 group or Ponatinib+E2 group ( P 〈0.05). Conclusion: VEGF and bFGF induced by E2 can active PI3K/AKT pathway ,and then promote the development and metastasis of endometrial cancer.
出处 《广西医科大学学报》 CAS 2015年第3期349-353,共5页 Journal of Guangxi Medical University
基金 国家自然科学基金资助项目(No.81160318) 广西自然科学基金资助项目(No.2013GXNSFAA019219)
关键词 子宫内膜癌 PI3K/AKT通路 VEGF BFGF endometrial cancer PI3K/AKT pathway VEGF bFGF
  • 相关文献

参考文献13

  • 1Matsumoto M, Yamaguchi Y, Seino Y, et al. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction[J]. Endocr Relat Canc- er, 2008,15 (2) :451-463.
  • 2丁兰芳,王晓谦,陆媛媛,宋红林,李力,张洁清.雌二醇对子宫内膜癌细胞AKT通路中细胞因子的影响[J].中国肿瘤临床,2011,38(20):1262-1266. 被引量:6
  • 3陆媛媛,张洁清,梁少凤,李力.雌激素通过激活AKT通路产生的细胞因子增强子宫内膜癌细胞增殖能力[J].中国癌症杂志,2013,23(11):868-873. 被引量:10
  • 4Kazi AA,Koos RD. Estrogen-induced activation of hy- poxia-inducible factor-lalpha, vascular endothelial growth factor expression,and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway[J]. Endocrinology, 2007,148(5) : 2 363-2 374.
  • 5Stanojevic Z, Djordj evic B, Todorovska I, et al. Risk fac- tors and adjuvant chemotherapy in the treatment of en- dometrial cancer[J]. J Buon,2008,13(1) - 23-30.
  • 6Matthews J,Wihlen B, Tujague M, et al. Estrogen re- ceptor (ER) beta modulates ERalpha-mediated tran- scriptional activation by altering the recruitment of c- Fos and c-Jun to estrogen-responsive promoters[J]. Mol Endocrinol,2006,20(3) : 534-543.
  • 7Rykala J, Przybylowska K, Maj sterek I, et al. Angiogen- esis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables [J]. Pathol Oncol Res,2011,17(4):809-817.
  • 8Gozgit JM, Squillace RM, Wongchenko MJ, et al. Com- bined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models[J]. CancerChemother Pharmacol, 2013,71(5) : 1 315-1 323.
  • 9Reck M,Kaiser R, Mellemgaard A, et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1) : a phase 3, double-blind, randomised controlled trial [J]. Lancet Oncol, 2014, 15 (2) : 143- 155.
  • 10Fearon AE, Gould CR, Grose RP. FGFR signalling in women's cancers[J]. Int J Biochem Cell Biol, 2013,45 (12) :2 832-2 842.

二级参考文献11

  • 1郭瑞霞,魏丽惠,王建六,孙蓬明,孙秀丽.17β-雌二醇对子宫内膜癌细胞磷脂酰肌醇3激酶/蛋白激酶B信号传导通路的激活作用[J].中华妇产科杂志,2004,39(7):469-473. 被引量:37
  • 2郭瑞霞,魏丽惠,王建六.17β-雌二醇对子宫内膜癌细胞磷脂酰肌醇3激酶/蛋白激酶B信号传导通路的活化[J].现代妇产科进展,2005,14(4):270-273. 被引量:11
  • 3汤建民,何权瀛,常秀军.磷酸化Akt和PTEN在非小细胞肺癌组织中的表达及其相关性[J].中国癌症杂志,2005,15(6):541-545. 被引量:6
  • 4MATHEWS J, WIHLEN B, TUJAGUE M, et al. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters [ J ] . Mol Endoerinol, 2006, 20(3): 534-543.
  • 5GUO R X, WEI L H, TU Z, et al. 1713 -Estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells [ J ]. J Steroid Biochem Mol Biol, 2006, 99(1): 9-18.
  • 6SKINNER H D, ZHENG J Z, FANG J, et al. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1 alpha, HDM2 and p70S6K1 in response to phosphatidylinositol 3 kinase/AKT signaling [ J ] . J Biol Chem, 2004, 279 (44): 45643- 45651.
  • 7JANG Y J, KIM D S, JEON 0 H, et al. Saxatilin suppresses tumor-induced angiogenesis by regulating VEGF expression in NCI-H460 human lung cancer cells [ J ] . J Biochem MolBiol, 2007, 40(3): 439-443.
  • 8MOLDOVAN N I. Angiogenesis, I' enfant terrible of vascular biology is coming of age [ J ] . J Cell Mol Med, 2005, 9(4): 775-776.
  • 9PRESTA M. Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenoearcinoma ceils: implications for the neovascularization of normal and neoplastic endometrium [ J ] . J Cell Physiol, 1998, 137(3): 593-597.
  • 10崔彬,姜汉国,肖静颖.pAKT和VEGF在Ⅰ型子宫内膜癌的表达及其临床意义[J].实用癌症杂志,2009,24(3):251-253. 被引量:2

共引文献14

同被引文献57

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部